MRK

Merck & Co., Inc.

MRK · CIK 310158

Latest 10-K filed February 24, 2026 · period ending December 31, 2023

Headline figures

Revenue

$60.12B

+1.4% vs prior year

Top-line sales for the most-recent fiscal year

FY2025 · 10-K

Net income

$365.0M

-97.5% vs prior year

Profit after all expenses, taxes, interest

FY2025 · 10-K

EPS (diluted)

$0.14

-97.5% vs prior year

Net income per diluted share outstanding

FY2025 · 10-K

Op. cashflow

$13.01B

-31.9% vs prior year

Cash actually generated by the business

FY2025 · 10-K

Balance sheet

Total assets

$117.11B

Everything the company owns

FY2025 · 10-K

Total liabilities

—

Everything the company owes

Stockholders equity

$46.31B

Assets minus liabilities (book value)

FY2025 · 10-K

Long-term debt

$34.46B

Debt due more than 12 months out

FY2025 · 10-K

Revenue history

Revenues · FY values from Revenues

Fiscal year	Revenue	vs prior	Source
FY2025	$60.12B	+1.4%	10-K
FY2024	$59.28B	+21.7%	10-K
FY2023	$48.70B	+17.3%	10-K
FY2022	$41.52B	+6.1%	10-K
FY2021	$39.12B	—	10-K

Read the source

All figures on this page were filed by Merck & Co., Inc. with the SEC and pulled directly from EDGAR's XBRL CompanyFacts API. Click below to view the latest annual report (10-K) in full.

Open latest 10-K on SEC EDGAR →

Not investment advice. Figures sourced from the SEC's XBRL CompanyFacts API — public-domain federal records. Companies occasionally restate prior-year numbers; we show the latest filed value per fiscal year.